Stevanato Group S.p.A. (STVN): Price and Financial Metrics

Stevanato Group S.p.A. (STVN): $27.95

0.91 (-3.15%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

STVN Price/Volume Stats

Current price $27.95 52-week high $36.30
Prev. close $28.86 52-week low $23.00
Day low $27.68 Volume 40,732
Day high $28.69 Avg. volume 326,358
50-day MA $30.71 Dividend yield N/A
200-day MA $30.13 Market Cap 8.26B

STVN Stock Price Chart Interactive Chart >


Stevanato Group S.p.A. (STVN) Company Bio


Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.


STVN Latest News Stream


Event/Time News Detail
Loading, please wait...

STVN Latest Social Stream


Loading social stream, please wait...

View Full STVN Social Stream

Latest STVN News From Around the Web

Below are the latest news stories about STEVANATO GROUP SPA that investors may wish to consider to help them evaluate STVN as an investment opportunity.

What Makes Stevanato Group S.p.A. (STVN) a Worthy Stock?

TimesSquare Capital Management, an equity investment management company, released its “U.S. SMID Cap Growth Strategy” third-quarter investor letter. The same can be downloaded here. In the third quarter, the U.S. SMID Cap Growth Composite fell -2.65% (gross) and -2.89% (net) compared to the Russell 2500 Growth Index’s -6.84% decline. This quarter, the small-to-mid-cap growth stocks […]

Yahoo | December 27, 2023

Will Stevanato Group S.p.A. (STVN) be Able to Drive Attractive Earnings Growth?

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned -7.98%, Advisor Class fund APDSX posted a return of -7.96%, and Institutional Class fund APHSX returned -7.97%, compared to a […]

Yahoo | December 1, 2023

Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing

PIOMBINO DESE, Italy, November 16, 2023--Stevanato Group (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life science industries, announced today that its Mavis™ Combi visual inspection machine has been selected as a winner of the 2023 Pharma Innovation Awards by Pharma Manufacturing, a brand of Endeavor Business Media.

Yahoo | November 16, 2023

Stevanato Group to Present at the Jefferies London Healthcare Conference

PIOMBINO DESE, Italy, November 09, 2023--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Jefferies London Healthcare Conference taking place from November 14, 2023 to November 16, 2023.

Yahoo | November 9, 2023

Stevanato Group S.p.A. (NYSE:STVN) Q3 2023 Earnings Call Transcript

Stevanato Group S.p.A. (NYSE:STVN) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the Stevanato Group Third Quarter 2023 Financial Results Conference Call. As a reminder, all participants are in listen-only mode. After the presentation, there will be an opportunity […]

Yahoo | November 1, 2023

Read More 'STVN' Stories Here

STVN Price Returns

1-mo -4.18%
3-mo -1.38%
6-mo -11.47%
1-year 4.64%
3-year N/A
5-year N/A
YTD 2.42%
2023 51.86%
2022 -19.96%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!